Chaparro M - Search Results

1

Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.

Casanova MJ, Nantes Ó, Varela P, Vela-González M, Rivero M, Sierra-Gabarda O, Riestra S, Barreiro-de Acosta M, Martín-Rodríguez MDM, Gargallo-Puyuelo CJ, Reygosa C, Muñoz R, de la Filia-Molina IG, Núñez-Ortiz A, Kolle L, Calafat M, Huguet JM, Iglesias-Flores E, Martínez-Pérez TJ, Bosch O, Duque-Alcorta JM, Frago-Larramona S, Van Domselaar M, González-Cosano VM, Bujanda L, Rubio S, Mancebo A, Castro B, García-López S, de Francisco R, Nieto-García L, Laredo V, Gutiérrez-Casbas A, Mesonero F, Leo-Carnerero E, Cañete F, Ruiz L, Gros B, Del Moral-Martínez M, Rodríguez C, Chaparro M, Gisbert JP. Casanova MJ, et al. Among authors: chaparro m. Aliment Pharmacol Ther. 2023 Jul;58(1):60-70. doi: 10.1111/apt.17525. Epub 2023 Apr 23. Aliment Pharmacol Ther. 2023. PMID: 37089065

2

Accuracy of computed tomographic colonography for the detection of polyps and colorectal tumors: a systematic review and meta-analysis.

Chaparro M, Gisbert JP, Del Campo L, Cantero J, Maté J. Chaparro M, et al. Digestion. 2009;80(1):1-17. doi: 10.1159/000215387. Epub 2009 May 4. Digestion. 2009. PMID: 19407448 Free article. Review.

3

Successful use of infliximab for perianal Crohn's disease in pregnancy.

Chaparro M, Gisbert JP. Chaparro M, et al. Inflamm Bowel Dis. 2011 Mar;17(3):868-9. doi: 10.1002/ibd.21368. Inflamm Bowel Dis. 2011. PMID: 20564533 No abstract available.

4

Prospective evaluation of a clinical guideline recommending early patients discharge in bleeding peptic ulcer.

Chaparro M, Barbero A, Martín L, Esteban C, Espinosa L, de la Morena F, Sánchez A, Martín I, Santander C, Moreno-Otero R, Gisbert JP. Chaparro M, et al. J Gastroenterol Hepatol. 2010 Sep;25(9):1525-9. doi: 10.1111/j.1440-1746.2010.06374.x. J Gastroenterol Hepatol. 2010. PMID: 20796150

5

Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.

Chaparro M, Panes J, García V, Mañosa M, Esteve M, Merino O, Andreu M, Gutierrez A, Gomollón F, Cabriada JL, Montoro MA, Mendoza JL, Nos P, Gisbert JP. Chaparro M, et al. J Clin Gastroenterol. 2011 Feb;45(2):113-8. doi: 10.1097/MCG.0b013e3181ebaef9. J Clin Gastroenterol. 2011. PMID: 21242747

6

Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease.

Chaparro M, Gisbert JP. Chaparro M, et al. Curr Pharm Biotechnol. 2011 May;12(5):765-73. doi: 10.2174/138920111795470903. Curr Pharm Biotechnol. 2011. PMID: 21342120 Review.

7

Utility of measuring serum concentrations of anti-TNF agents and anti-drug antibodies in inflammatory bowel disease.

Guerra I, Chaparro M, Bermejo F, Gisbert JP. Guerra I, et al. Among authors: chaparro m. Curr Drug Metab. 2011 Jul;12(6):594-8. doi: 10.2174/138920011795713689. Curr Drug Metab. 2011. PMID: 21495977

8

Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.

López-Martín C, Chaparro M, Espinosa L, Bejerano A, Maté J, Gisbert JP. López-Martín C, et al. Among authors: chaparro m. Gastroenterol Hepatol. 2011 Jun-Jul;34(6):385-92. doi: 10.1016/j.gastrohep.2011.03.023. Epub 2011 May 25. Gastroenterol Hepatol. 2011. PMID: 21616565

9

Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.

Fortea-Ormaechea JI, González-Lama Y, Casis B, Chaparro M, López Serrano P, Van Domselaar M, Bermejo F, Pajares R, Ponferrada A, Vera MI, Martínez Montiel P, Gisbert JP, Pérez-Calle JL, López San Román A, Abreu L, Menchén LA, Marín-Jiménez I. Fortea-Ormaechea JI, et al. Among authors: chaparro m. Gastroenterol Hepatol. 2011 Aug-Sep;34(7):443-8. doi: 10.1016/j.gastrohep.2011.04.001. Epub 2011 Jul 2. Gastroenterol Hepatol. 2011. PMID: 21724297

10

Methotrexate in ulcerative colitis: a Spanish multicentric study on clinical use and efficacy.

Mañosa M, García V, Castro L, García-Bosch O, Chaparro M, Barreiro-de Acosta M, Carpio D, Aguas M. Mañosa M, et al. Among authors: chaparro m. J Crohns Colitis. 2011 Oct;5(5):397-401. doi: 10.1016/j.crohns.2011.03.012. Epub 2011 Apr 22. J Crohns Colitis. 2011. PMID: 21939912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page